|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
|
|---|---|---|---|---|
| Assets | ||||
| Current assets: | ||||
| Cash and cash equivalents | ||||
| Marketable securities | ||||
| Prepaid expenses and other current assets | ||||
| Total current assets | ||||
| Deferred offering costs | ||||
| Property and equipment, net | ||||
| Other assets | ||||
| Total assets | ||||
| Liabilities, Convertible Preferred Stock and Equity (Deficit) | ||||
| Current liabilities: | ||||
| Accounts payable | ||||
| Accrued liabilities | ||||
| Current portion of long-term debt, less discount of $190 and $0, respectively | ||||
| Total current liabilities | ||||
| Note payable | ||||
| Long-term debt, less discount of $405 and $580, respectively | ||||
| Other long-term liabilities | ||||
| Total liabilities | ||||
| Equity (deficit): | ||||
| Common stock, par value $0.0001; 200,000,000 and 86,500,000 shares authorized at December, 31, 2014 and December, 31, 2013, respectively; 27,748,264 and 1,128,702 issued and 27,123,554 and 173,147 outstanding, excluding 624,710 and 955,555 shares subject to repurchase at December, 31, 2014 and December, 31, 2013, respectively | ||||
| Additional paid-in capital | ||||
| Deficit accumulated during the development stage | ||||
| Accumulated deficit | ||||
| Accumulated other comprehensive income | ||||
| Total Auspex stockholders’ equity (deficit) | ||||
| Noncontrolling interest in variable interest entity | ||||
| Total equity (deficit) | ||||
| Total liabilities, convertible preferred stock and equity (deficit) |
Loading...
